Search Results - "MAIORANA, A"

Mechanical and structural comparison between primary tumor and lymph node metastasis cells in colorectal cancer by Palmieri, V, Lucchetti, D, Maiorana, A, Papi, M, Maulucci, G, Calapà, F, Ciasca, G, Giordano, R, Sgambato, A, De Spirito, M

“…SW480 and SW620 colon carcinoma cell lines derive from primary tumour and lymph-node metastasis of the same patient, respectively. For this reason, these cells…”
Get more information

Models of radon exhalation from building structures: General and case-specific solutions by Di Carlo, C., Maiorana, A., Ampollini, M., Antignani, S., Caprio, M., Carpentieri, C., Bochicchio, F.

“…Assessing the radon activity that exhales from building structures is crucial to identify the best strategies to prevent radon from entering a building or…”
Get full text

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer by Dieci, M.V., Conte, P., Bisagni, G., Brandes, A.A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S., D’Amico, R., Guarneri, V.

“…There is the need to identify new prognostic markers to refine risk stratification for HER2-positive early breast cancer patients. The aim of this study was to…”
Get full text

Stearoyl-CoA desaturase 1 and paracrine diffusible signals have a major role in the promotion of breast cancer cell migration induced by cancer-associated fibroblasts by Angelucci, C, Maulucci, G, Colabianchi, A, Iacopino, F, D'Alessio, A, Maiorana, A, Palmieri, V, Papi, M, De Spirito, M, Di Leone, A, Masetti, R, Sica, G

“…Background: Despite the recognised contribution of the stroma to breast cancer development and progression, the effective targeting of the tumor…”
Get full text

Deep inside of gastric signet-ring cell carcinoma by Roncati, L, Manenti, A, Barbolini, G, Maiorana, A

“…The histology of signet-ring cell carcinoma (SRC) of the stomach has been revisited with the support of current immuno- histochemical techniques in order to…”
Get more information

The impact of cognitive training in substance use disorder: the effect of working memory training on impulse control in methamphetamine users by Brooks, Samantha J., Wiemerslage, L, Burch, KH, Maiorana, SA, Cocolas, E, Schiöth, HB, Kamaloodien, K, Stein, DJ

“…Objectives Impulsivity is a vulnerability trait for poor self-regulation in substance use disorder (SUD). Working memory (WM) training improves impulsivity and…”
Get full text

Nivolumab in metastatic melanoma: good efficacy and tolerability in elderly patients by De Luca, R, Meraviglia, S, Blasi, L, Maiorana, A, Cicero, G

“…Nivolumab is an anti-PD-1 antibody that restores the antitumour immune function of T cells, blocking the binding of PD-1 with its ligand PD-L1. PD-1 is…”
Get full text

Efficacy of dienogest in improving pain in women with endometriosis: a 12-month single-center experience by Maiorana, A., Incandela, Domenico, Parazzini, F., Alio, W., Mercurio, A., Giambanco, L., Alio, L.

“…Purpose Dienogest has recently been marketed as a medical treatment for endometriosis. Given the recent introduction on the market of Dienogest, little data…”
Get full text

Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas by Luminari, S., Cesaretti, M., Marcheselli, L., Rashid, I., Madrigali, S., Maiorana, A., Federico, M.

“…Few studies have been carried out to date that have addressed the epidemiology of extranodal marginal zone lymphomas (EN-MZLs). We carried out a…”
Get full text

A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy by Guarneri, V., Piacentini, F., Ficarra, G., Frassoldati, A., D'Amico, R., Giovannelli, S., Maiorana, A., Jovic, G., Conte, P.

“…Background: Preoperative chemotherapy (PCT) allows for in vivo testing of treatment effects on tumor and its microenvironment. Aim of this analysis was to…”
Get full text

Endometriosis: seeking optimal management in women approaching menopause by Alio, L., Angioni, S., Arena, S., Bartiromo, L., Bergamini, V., Berlanda, N., Bonanni, V., Bonin, C., Buggio, L., Candiani, M., Centini, G., D'Alterio, M. N., De Stefano, F., Di Cello, A., Exacoustos, C., Fedele, L., Frattaruolo, M. P., Geraci, E., Lavarini, E., Lazzeri, L., Luisi, S., Maiorana, A., Makieva, S., Maneschi, F., Martire, F., Massarotti, C., Mattei, A., Muzii, L., Ottolina, J., Pagliardini, L., Perandini, A., Perelli, F., Pino, I., Porpora, M. G., Remorgida, V., Scagnelli, G., Seracchioli, R., Solima, E., Somigliana, E., Sorrenti, G., Ticino, A., Venturella, R., Viganò, P., Vignali, M., Zullo, F., Zupi, E.

“…The incidence of endometriosis in middle-aged women is not minimal compared to that in the reproductive age group. The treatment of affected women after…”
Get full text

Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumour invasion by Dallaglio, K, Petrachi, T, Marconi, A, Truzzi, F, Lotti, R, Saltari, A, Morandi, P, Puviani, M, Maiorana, A, Pincelli, C

“…Background: Survivin is detected in few adult normal cells and it is highly expressed in cancer. Nuclear survivin facilitates cell cycle entry, whereas the…”
Get full text

Early effect of NTBC on renal tubular dysfunction in hereditary tyrosinemia type 1 by Maiorana, A., Malamisura, M., Emma, F., Boenzi, S., Di Ciommo, V.M., Dionisi-Vici, C.

“…Hereditary tyrosinemia type 1 (HT1) is characterized by severe progressive liver disease and renal tubular dysfunction. NTBC therapy has revolutionized the…”
Get full text

Towards patient dose optimization in digital radiography by Andria, G., Attivissimo, F., Guglielmi, G., Lanzolla, A.M.L., Maiorana, A., Mangiantini, M.

“…Digital radiographic imaging systems cover a wide range of clinical applications and can produce adequate image quality using a broad span of exposure levels…”
Get full text

Role of evaluating tumor infiltrating lymphocytes, programmed death-ligand 1 and mismatch-repair proteins expression in malignant mesothelioma by Losi, L., Bertolini, F., Scurani, L., Guaitoli, G., Baldessari, C., Ambrosini Spaltro, A., Botticelli, L., Maiorana, A., Barbieri, F., Cascinu, S.

Get full text

A cross-sectional study on smartphone uses among pregnant women attending childbirth classes in the Metropolitan Area of Palermo, Italy: The Stop-Phone study by Costantino, C, Mazzucco, W, Bonaccorso, N, Sciortino, M, Cimino, L, Pizzo, S, Conforto, A, Calò, I, Gilimberti, D, Gambino, C R, Segreto, D, Maiorana, A, Vitale, F, Casuccio, A

“…Prevalence of mobile device addiction has increased over the years; both women and men have assimilated the mobile phone as a central component of their…”
Get more information

Social contributors to cardiometabolic diseases in indigenous populations: an international Delphi study by Stoner, L., Matheson, A.G., Perry, L.G., Williams, M.A., McManus, A., Holdaway, M., Dimer, L., Joe, J.R., Maiorana, A.

“…The objective of this study was to identify priority social factors contributing to indigenous cardiometabolic diseases. A three-round Delphi process was used…”
Get full text

Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status by Omarini, C, Kaleci, S, Guaitoli, G, Bettelli, S, Caprera, C, Manfredini, S, Caggia, F, Baschieri, M C, Moscetti, L, Maiorana, A, Cascinu, S, Piacentini, F

Get full text

New advances on placental hydrops and related villous lymphatics by Roncati, L, Barbolini, G, Pusiol, T, Piscioli, F, Maiorana, A

“…Fetoplacental hydrops is the final stage of several pathological conditions in which the placenta and umbilical cord become edematous and the fetus develops an…”
Get full text

Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial by Dieci, M.V., Conte, P.F., Bisagni, G., Brandes, A.A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Omarini, C., Maiorana, A., Orvieto, E., Sanders, M., D'Amico, R., Guarneri, V.

Get full text